CLIFFSIDE LABS L.L.C. NPI 1518366426

NPI Details

CLIFFSIDE LABS L.L.C. is a clinical medical laboratory in Monmouth, NJ. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. CLIFFSIDE LABS L.L.C. NPI is 1518366426. The provider is registered as an organization entity type.

The provider's business location address is:

7 DEER PARK DRIVE, STE K
MONMOUTH, NJ
ZIP 08852-977
Phone: (609) 964-7620
Fax: (732) 647-1225

The provider's authorized official is Liam J Dunne .
The authorized official title is Authorized Official and has the following contact phone number (609) 964-7620.

The CLIA number assigned to this NPI record is 31D2096452 - independent with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Gene analysis (partner and localizer of brca2) full sequence analysis (HCPCS:81307)
• Gene analysis (bloom syndrome, recq helicase-like) (HCPCS:81209)
• Gene analysis (fanconi anemia, complementation group c) common variant (HCPCS:81242)
• Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis (HCPCS:81317)
• Gene analysis (muts homolog 6 [e coli]) full sequence analysis (HCPCS:81298)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10 (HCPCS:81339)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence (HCPCS:81223)
• Gene analysis (glucose-6-phosphatase, catalytic subunit) common variants (HCPCS:81250)
• Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis (HCPCS:81249)
• Gene analysis (coagulation factor ix) full sequence analysis (HCPCS:81238)
• Gene analysis (muts homolog 6 [e coli]) duplication or deletion variants (HCPCS:81300)
• Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) duplication or deletion variants (HCPCS:81319)
• Test for detecting genes associated with colon cancer, genomic sequence analysis panel, at least 10 genes (HCPCS:81435)
• Gene analysis (adenomatous polyposis coli), duplication or deletion variants (HCPCS:81203)
• Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis (HCPCS:81295)
• Gene analysis (adenomatous polyposis coli), full gene sequence (HCPCS:81201)
• Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants (HCPCS:81162)
• Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) duplication or deletion variants (HCPCS:81297)
• Gene analysis (mutl homolog 1, colon cancer, nonpolyposis type 2) duplication or deletion variants (HCPCS:81294)
• Gene analysis (phosphatase and tensin homolog), full sequence analysis (HCPCS:81321)
• Gene analysis (mutl homolog 1, colon cancer, nonpolyposis type 2) full sequence analysis (HCPCS:81292)
• Gene analysis (phosphatase and tensin homolog), duplication or deletion variant (HCPCS:81323)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0482)
• Gene analysis for cancer (neuroblastoma) (HCPCS:81311)
• Gene analysis (breast cancer 2) of full sequence (HCPCS:81216)
• Gene analysis (runt related transcription factor 1) targeted sequence analysis (HCPCS:81334)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0483)
• Gene analysis (phospholipase c gamma 2) for common variants (HCPCS:81320)
• Gene analysis (myeloid differentiation primary response 88) for p.leu265pro variant (HCPCS:81305)
• Gene analysis (coagulation factor v) leiden variant (HCPCS:81241)
• Gene analysis (telomerase reverse transcriptase) targeted sequence analysis (HCPCS:81345)
• Gene analysis (tumor protein 53) full sequence analysis (HCPCS:81351)
• Molecular pathology procedure level 4 (HCPCS:81403)
• Molecular pathology procedure level 5 (HCPCS:81404)
• Molecular pathology procedure level 6 genetic analysis (HCPCS:81405)

The enumeration date for this NPI number is 8/15/2014 and was last updated on 9/25/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: